147 related articles for article (PubMed ID: 19890661)
1. Vascular endothelial growth factor and endoglin expression in colorectal cancer.
Dassoulas K; Gazouli M; Theodoropoulos G; Christoni Z; Rizos S; Zisi-Serbetzoglou A; Glava C; Karantanos T; Klonaris C; Karakitsos P
J Cancer Res Clin Oncol; 2010 May; 136(5):703-8. PubMed ID: 19890661
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer.
Nikiteas NI; Tzanakis N; Theodoropoulos G; Atsaves V; Christoni Z; Karakitsos P; Lazaris AC; Papachristodoulou A; Klonaris C; Gazouli M
Gastric Cancer; 2007; 10(1):12-7. PubMed ID: 17334712
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
[TBL] [Abstract][Full Text] [Related]
4. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
6. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs.
Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C
J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314
[TBL] [Abstract][Full Text] [Related]
7. Combined perioperative plasma endoglin and VEGF-A assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2008; 46(4):487-92. PubMed ID: 19141403
[TBL] [Abstract][Full Text] [Related]
8. Endoglin as a marker in cervical paragangliomas.
Eleno N; Düwel A; Muñoz A; Paz-Bouza J; López-Novoa JM; Lozano F
Head Neck; 2010 Jun; 32(6):737-43. PubMed ID: 19827102
[TBL] [Abstract][Full Text] [Related]
9. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
10. Combined perioperative plasma endoglin and VEGF--a assessment in colorectal cancer patients.
Myśliwiec P; Pawlak K; Kukliński A; Kedra B
Folia Histochem Cytobiol; 2009; 47(2):231-6. PubMed ID: 19995709
[TBL] [Abstract][Full Text] [Related]
11. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
12. Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer.
Ilhan N; Gungor H; Gul HF; Eroksuz H
Anticancer Res; 2016 Aug; 36(8):3953-9. PubMed ID: 27466499
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
14. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
15. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
16. Expression of endoglin (CD105) in cervical cancer.
Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
[TBL] [Abstract][Full Text] [Related]
17. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
18. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients.
Ocaña A; Rodríguez-Barbero A; Pericacho M; Bellido L; Seijas R; López R; Delgado C; de Prado DS; Cruz-Hernández JJ; López-Novoa JM
Cancer Lett; 2007 Sep; 255(1):71-6. PubMed ID: 17482348
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]